GSK's Meningococcal Disease Vaccine Gets EU Recommendation for Newborns
MT newswire2026/11/13 11:41Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:41 AM EST, 11/13/2026 (MT Newswires) -- GSK's (GSK) Bexsero received a recommendation from the European Medicines Agency to immunize newborns against meningococcal disease, the regulator said Friday. The EMA's Committee for Medicinal Products for Human Use recommended the vaccine for meningococcal disease caused by Neisseria meningitidis group B in children from 6 weeks of age and older, compared with two months and older previously, the regulator said.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$68,644.45
-4.37%
Ethereum
ETH
$1,927.03
-4.02%
Tether USDt
USDT
$0.9994
+0.04%
BNB
BNB
$631.46
-3.61%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$1.02
-0.73%
Solana
SOL
$79.51
-2.41%
TRON
TRX
$0.3130
-0.86%
Hyperliquid
HYPE
$72.56
+1.98%
Zcash
ZEC
$948.24
-0.66%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now